Woodford Investment Management (WIM) is to take a 15% performance fee of any excess returns above the 10% annual return target on its Patient Capital investment trust.
News of Neil Woodford's forthcoming trust investing in early stage companies has prompted comparisons with venture capital trusts (VCTs), but analysts say they are unlikely to appeal to the same kinds of investors.
Investment Quorum has unveiled a series of funds it is backing to navigate currency wars and unpredictable central bank action in 2015, said the group's CIO Peter Lowman.
Woodford Investment Management (WIM) is seeking to raise an initial £200m for the launch of the Woodford Patient Capital investment trust, a portfolio of 50-100 quoted and unquoted businesses.
The changing face of investment over 20 years
Lower oil prices have been hailed as a welcome boost to the global economy, but could they also be a harbinger of declining demand in the global economy? Woodford IM's Stephen Lamacraft explains.
Dr Nicholas Motson (pictured), a lecturer in finance at the Cass Business School, has called for greater disclosure of fund holdings in order to allow researchers to calculate retail funds' "active share".
Aviva has written to advisers outlining its views on the challenges facing Mark Barnett, following a review of how he runs funds previously managed by Neil Woodford.
Woodford Investment Management has brought in a new head of operations after the departure of two senior executives less than a year after the business launched.
Woodford Investment Management topped the sales chart in the third quarter, despite subdued inflows into funds across the board, according to the latest Pridham Report.